These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4971006)

  • 1. [The state of hemopoiesis in the regional perfusion of malignant tumors of the extremities with sarcolysin, thio-TEPA and cyclophosphane].
    Levin AO; Babinina VF
    Vopr Onkol; 1967; 13(2):48-54. PubMed ID: 4971006
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-electrocardiographic changes during perfusion chemotherapy of malignant tumors of the extremities].
    Levin AO; Volodkovich HG
    Vopr Onkol; 1970; 16(8):3-7. PubMed ID: 4993603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in several hematologic indices under the effects of perfusion with thio-tepa].
    Sergienko TM; Guchek IuL
    Vrach Delo; 1967; 7():81-3. PubMed ID: 4987713
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
    Hara J; Osugi Y; Ohta H; Matsuda Y; Nakanishi K; Takai K; Fujisaki H; Tokimasa S; Fukuzawa M; Okada A; Okada S
    Bone Marrow Transplant; 1998 Jul; 22(1):7-12. PubMed ID: 9678789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse effect of thio tepa on the hemopoiesis and complications arising with it].
    Andriukin AA; Vinogradova ON; Akhtomova LV
    Sov Med; 1968 Sep; 31(9):127-9. PubMed ID: 4989665
    [No Abstract]   [Full Text] [Related]  

  • 6. [Depression of bone marrow after intravesical use of Thio-tepa].
    Malling N
    Ugeskr Laeger; 1980 Sep; 142(40):2630-1. PubMed ID: 6777928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of autologous preserved marrow on patients undergoing myelodepressive therapeutic treatment].
    Polese E; Massenti S; Rossi-Torelli M
    Minerva Med; 1970 Sep; 61(77):4159-62. PubMed ID: 4921987
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
    Nathanson L; Hall TC; Schilling A; Miller S
    Cancer Res; 1969 Feb; 29(2):419-25. PubMed ID: 4885390
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of radiotherapy and chemotherapy on the granulocytic reserve of the bone marrow in cancer of the genitalia].
    Kosareva AN; Turbina IL; Urvantseva NV
    Vopr Onkol; 1971 Dec; 17(12):38-9. PubMed ID: 5004141
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood changes in hyperthermic perfusion with chemotherapeutic preparations].
    Voronko EA; Fradkin SZ
    Vopr Onkol; 1974; 20(1):98. PubMed ID: 4216151
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of autotransplantation of bone marrow in the restoration of hematopoiesis in oncological patients being treated with sarcolysin].
    Zhukovskiĭ IIa
    Probl Gematol Pereliv Krovi; 1975 Dec; 20(12):33-6. PubMed ID: 781664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
    Schubert JC; Ischer M; Hilbert L
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cystamine on cytogenetic changes in bone marrow cells and lymphocytes of the peripheral blood in patients with bronchial cancer treated with thio-TEPA].
    Drukin EIa; Smirnov AD; Berlin LB
    Klin Med (Mosk); 1970 Dec; 48(12):48-52. PubMed ID: 4996609
    [No Abstract]   [Full Text] [Related]  

  • 14. [Status of the blood after perfusion with various doses of chemopreparations and the efficiency of an artificial ciruclation device in malignant tumors of the extremities].
    Antelava NV; Trapeznikov NN; Iavorskiĭ VV; Amcheslavskiĭ EG
    Vestn Khir Im I I Grek; 1968 Aug; 101(8):31-5. PubMed ID: 4973965
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy].
    Kolessov VI; Levin AO
    Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391
    [No Abstract]   [Full Text] [Related]  

  • 16. Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC).
    Meisenberg BR; Miller WE; McMillan R
    Bone Marrow Transplant; 1996 Dec; 18(6):1087-93. PubMed ID: 8971377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
    Weaver CH; Bensinger WI; Appelbaum FR; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
    Bone Marrow Transplant; 1994 Nov; 14(5):813-9. PubMed ID: 7889015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
    Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
    Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic analysis of the damaging effect of thiophosphamide on the bone marrow of patients with malignant tumors].
    Blank MA
    Vopr Onkol; 1979; 25(10):72-3. PubMed ID: 116421
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complications during treatment of patients with malignant neoplasms of the larynx with antitumor preparations].
    Svetlakov MI; Kravchenko AA
    Zh Ushn Nos Gorl Bolezn; 1964; 24(4):10-4. PubMed ID: 4961005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.